Free Trial

Takeda Pharmaceutical (TAK) Stock Forecast & Price Target

+0.04 (+0.30%)
(As of 07/12/2024 ET)

Takeda Pharmaceutical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

4.17% Upside
High Forecast$14.00
Average Forecast$14.00
Low Forecast$14.00
TypeCurrent Forecast
7/15/23 to 7/14/24
1 Month Ago
6/15/23 to 6/14/24
3 Months Ago
4/16/23 to 4/15/24
1 Year Ago
7/15/22 to 7/15/23
Consensus RatingN/AN/AN/A
Moderate Buy
Strong Buy N/A N/A N/A
0 Strong Buy rating(s)
Buy N/A N/A N/A
4 Buy rating(s)
Hold N/A N/A N/A
1 Hold rating(s)
Sell N/A N/A N/A
0 Sell rating(s)
Consensus Price Target$14.00$14.00$14.00$24.67
Forecasted Upside4.17% Upside-9.06% Downside-9.06% Downside56.91% Upside
Get Takeda Pharmaceutical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.

TAK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TAK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Takeda Pharmaceutical Stock vs. The Competition

TypeTakeda PharmaceuticalMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingN/AModerate BuyModerate Buy
Predicted Upside4.17% Upside994.16% Upside9.20% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/1/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$14.20 ➝ $14.00-9.06%
4/4/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$24.00 ➝ $30.00+79.96%
3/16/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$20.00+24.38%
7/29/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$21.00 ➝ $24.00+66.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:16 AM ET.

TAK Forecast - Frequently Asked Questions

What is Takeda Pharmaceutical's forecast for 2024?

According to the research reports of 0 Wall Street equities research analysts, the average twelve-month stock price forecast for Takeda Pharmaceutical is $14.00, with a high forecast of $14.00 and a low forecast of $14.00.

Does Takeda Pharmaceutical's stock price have much downside?

According to analysts, Takeda Pharmaceutical's stock has a predicted downside of -9.06% based on their 12-month stock forecasts.

This page (NYSE:TAK) was last updated on 7/14/2024 by Staff

From Our Partners